MiNK Therapeutics Balance Sheet
MiNK Therapeutics's total assets for Q4 2025 were $14.24M, a decrease of -4.84% from the previous quarter. INKT total liabilities were $28.47M for the fiscal quarter, a -0.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.